Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advances in the management of Ph-positive ALL.

× No keyword cloud information.

7 in total

1. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors: Ehsan Valiollahi; Josep Maria Ribera; Eulàlia Genescà; Javad Behravan
Journal: Mol Biol Rep Date: 2019-02-02 Impact factor: 2.316

2. Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.

Authors: Farhad Ravandi; Jeffrey L Jorgensen; Deborah A Thomas; Susan O'Brien; Rebecca Garris; Stefan Faderl; Xuelin Huang; Sijin Wen; Jan A Burger; Alessandra Ferrajoli; Partow Kebriaei; Richard E Champlin; Zeev Estrov; Pramoda Challagundla; Sa A Wang; Rajyalakshmi Luthra; Jorge E Cortes; Hagop M Kantarjian
Journal: Blood Date: 2013-07-08 Impact factor: 22.113

Review 3. Treatment of acute lymphoblastic leukaemia : a new era.

Authors: Effrosyni Apostolidou; Ronan Swords; Yesid Alvarado; Francis J Giles
Journal: Drugs Date: 2007 Impact factor: 9.546

4. Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002.

Authors: Gemma Gatta; Silvia Rossi; Roberto Foschi; Annalisa Trama; Rafael Marcos-Gragera; Guido Pastore; Rafael Peris-Bonet; Charles Stiller; Riccardo Capocaccia
Journal: Haematologica Date: 2013-02-12 Impact factor: 9.941

Review 5. Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors: Farhad Ravandi; Partow Kebriaei
Journal: Hematol Oncol Clin North Am Date: 2009-10 Impact factor: 3.722

6. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors: Farhad Ravandi; Susan M O'Brien; Jorge E Cortes; Deborah M Thomas; Rebecca Garris; Stefan Faderl; Jan A Burger; Michael E Rytting; Alessandra Ferrajoli; William G Wierda; Srdan Verstovsek; Richard Champlin; Partow Kebriaei; Deborah A McCue; Xuelin Huang; Elias Jabbour; Guillermo Garcia-Manero; Zeev Estrov; Hagop M Kantarjian
Journal: Cancer Date: 2015-08-26 Impact factor: 6.860

7. Prognostic value of MRD monitoring based on BCR-ABL1 copy numbers in Philadelphia chromosome positive acute lymphoblastic leukemia.

Authors: Arun Kumar Arunachalam; Nancy Beryl Janet; Anu Korula; Kavitha M Lakshmi; Uday P Kulkarni; Fouzia N Aboobacker; Aby Abraham; Biju George; Poonkuzhali Balasubramanian; Vikram Mathews
Journal: Leuk Lymphoma Date: 2020-08-27

7 in total